108 related articles for article (PubMed ID: 14964088)
1. [p53 and Ki67 expression in specimens of radical prostatectomy. Relationship with clinico-pathologic data and survival].
Zudaire Bergera JJ; Sánchez Zalabardo D; Arocena García-Tapia J; Sanz Pérez G; Díez Caballero F; López Ferrandis J; Rosell Costa D; Robles García JE; de Alava E; Berián Polo JM
Actas Urol Esp; 2000 Apr; 24(4):307-13. PubMed ID: 14964088
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population.
Inoue T; Segawa T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Kinoshita H; Kamoto T; Ogawa O
Urology; 2005 Aug; 66(2):332-7. PubMed ID: 16098362
[TBL] [Abstract][Full Text] [Related]
3. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.
Antonarakis ES; Keizman D; Zhang Z; Gurel B; Lotan TL; Hicks JL; Fedor HL; Carducci MA; De Marzo AM; Eisenberger MA
Cancer; 2012 Dec; 118(24):6063-71. PubMed ID: 22674438
[TBL] [Abstract][Full Text] [Related]
5. [The usefulness of Ki67 expression in the biopsy specimens, to predict the biochemical progresion of the prostate cancer after radical prostatectomy].
Ojea Calvo A; Mosteiro Cerviño MJ; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; González Piñeiro A
Actas Urol Esp; 2004 Oct; 28(9):650-60. PubMed ID: 16050199
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
Int J Cancer; 2001 Sep; 95(5):337-42. PubMed ID: 11494236
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
Osman I; Drobnjak M; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 Aug; 5(8):2082-8. PubMed ID: 10473090
[TBL] [Abstract][Full Text] [Related]
9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
Grossfeld GD; Carroll PR; Lindeman N; Meng M; Groshen S; Feng AC; Hawes D; Cote RJ
Urology; 2002 Jan; 59(1):97-102. PubMed ID: 11796289
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
[TBL] [Abstract][Full Text] [Related]
12. p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.
Bauer JJ; Sesterhenn IA; Mostofi KF; McLeod DG; Srivastava S; Moul JW
Clin Cancer Res; 1995 Nov; 1(11):1295-300. PubMed ID: 9815924
[TBL] [Abstract][Full Text] [Related]
13. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.
Bubendorf L; Tapia C; Gasser TC; Casella R; Grunder B; Moch H; Mihatsch MJ; Sauter G
Hum Pathol; 1998 Sep; 29(9):949-54. PubMed ID: 9744310
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy.
Kuczyk MA; Serth J; Bokemeyer C; Machtens S; Minssen A; Bathke W; Hartmann J; Jonas U
Eur J Cancer; 1998 Apr; 34(5):679-86. PubMed ID: 9713274
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Oxley JD; Abbott CD; Gillatt DA; MacIver AG
Br J Urol; 1998 Jan; 81(1):109-15. PubMed ID: 9467486
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
Krupski T; Petroni GR; Frierson HF; Theodorescu JU
Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
[TBL] [Abstract][Full Text] [Related]
18. [Radical prostatectomy in clinically localized prostatic adenocarcinoma. Study of patients with positive margins and their impact on survival free from biochemical progression].
Zudaire Bergera JJ; Martín-Marquina Aspiunza A; Sánchez Zalabardo D; Arocena García-Tapia J; Sanz Pérez G; Diez Caballero F; Rosell Costa D; Robles García JE; Berián Polo JM
Actas Urol Esp; 1999; 23(10):835-42. PubMed ID: 10670124
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer.
Leibovich BC; Cheng L; Weaver AL; Myers RP; Bostwick DG
J Urol; 2000 Jun; 163(6):1756-60. PubMed ID: 10799176
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
Quinn DI; Henshall SM; Head DR; Golovsky D; Wilson JD; Brenner PC; Turner JJ; Delprado W; Finlayson JF; Stricker PD; Grygiel JJ; Sutherland RL
Cancer Res; 2000 Mar; 60(6):1585-94. PubMed ID: 10749127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
